期刊文献+

^(131)I标记的抗甲状腺髓样癌人源单链抗体在荷瘤裸鼠的体内分布和放射免疫显像 被引量:2

Diodistribution and radioimmunoimaging of ^(131)I labeled scFv anti-medullary thyroid carcinoma in tumor bearing nude mice
下载PDF
导出
摘要 目的测定^(131)I标记的抗甲状腺髓样癌(MTC)人源单链抗体(scFv)的放射化学纯度,并研究荷MTC细胞(TT cells)裸鼠^(131)I-scFv体内分布和体外放射免疫(RII)显像特点。方法氯胺T法对scFv进行^(131)I标记,Sephadex G200纯化标记抗体,三氯醋酸沉淀法测定标记率,纸层析法测定标记抗体在1、6、12、24h的放射化学纯度、室温稳定性和血清稳定性。构建荷TT细胞裸鼠模型,尾静脉注射^(131)I-scFv,分析^(131)I-scFv在裸鼠重要组织器官的分布情况,并于注射药物12、24、48、72h行SPECT正位静态显像,观察肿瘤内放射性浓集情况,肿瘤组织显像清晰时行SPECT/CT融合图像。结果标记抗体经纯化后,测得标记率为(78.60±0.08)%,放射化学纯度为(87.10±0.78)%,各个时间点的放射化学纯度均在90%以上。荷瘤裸鼠体内研究结果显示,^(131)I-scFv的放射性瘤/血、瘤/肌肉比值随时间的增长逐渐增高,48h达最高。RII显示,^(131)I-scFv可选择性聚集于肿瘤组织,48h时肿瘤显像与全身组织对比最清晰,此时融合图像可清晰显示肿瘤部位的放射性浓聚情况,体内分布和体外显像结果一致。结论成功标记了抗MTC人源scFv,生物活性较高,荷瘤裸鼠肿瘤的RII较好。 Objective To observe the radiochemical purity of ^131I-labeled human single-chain antibody(scFv),and to analyze the distribution of ^131I-scFv in vitro and radioimmunoimaging(RII)in nude mice xenografted with medullary thyroid carcinoma(MTC)cells in vivo.Methods Specific anti-MTC^131I-scFv was labeled with chloramine T method,labeled scFv was puritied by Sephadex G200,labeling efficiency was measured with trichloroacetic acid precipitation method.Radiochemical purity,room temperature stability and serum stability of ^131I-scFv at 1h,6h,12 h,24hwas determined by paper chromatography.^131I-scFv was injected into the tail veins of nude mice xenografted with medullary thyroid carcinoma cells(TT cells)to analyze the distribution in various tissues and organs of mice.Anteroposterior static imaging was performed with SPECT at 12,24,48,72 hafter injection of ^131I-scFv to observe the radioactivity in tumor.Image fusion was performed with SPECT/CT when the tumor tissues was clearly visible.Results Labeling rate of purified ^131I-scFv was(78.60±0.08)%,radiochemical purity was(87.10±0.78)%,radiochemical purity at each time point were more than90%.Nude mice in vivo studies showed that with the increase of time,^131I-scFv radiological tumor/blood and tumor/muscle ratio increased after injection ^131I-scFv,which reached the highest at 48 h.The RII showed that the ^131I-scFv selectively accumulated in tumor tissue,and tumor imaging was most clear at 48 h.The image was well fused and the tumor was clearly seen at 48 hafter injection of ^131I-scFv.Conclusion Anti-MTC scFv can be successfully prepared and shows a high biological activity.Nude mice tumor RII shows a clear image.
出处 《中国医学影像技术》 CSCD 北大核心 2016年第1期3-7,共5页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(81071171)
关键词 甲状腺肿瘤 放射免疫显像 正电子发射断层显像术 Thyroid neoplasms Radioimmunodetection Positron-emission tomography
  • 相关文献

参考文献4

二级参考文献31

  • 1Paul E.VAN SCHIL Michèle DE WAELE Jeroen M.HENDRIKS Patrick R.LAUWERS.Is there a role for surgery in stage ⅢA-N2 non-small cell lung cancer?[J].中国肺癌杂志,2008,11(5):615-621. 被引量:14
  • 2赵岩,王清明,付学奇,陈吉中,范国才,陈惠鹏.噬菌体抗体库的构建及抗乳腺癌细胞单链抗体的筛选[J].生物工程学报,2004,20(5):667-672. 被引量:6
  • 3刘卫红,李志,王鹏,刘会娟,闫平平,王凯娟,代丽萍,张建营.肿瘤相关抗原抗体联合检测在肺癌早期诊断中的价值评价[J].中国卫生检验杂志,2006,16(12):1412-1414. 被引量:11
  • 4Ikeda K, Nomori H, Mori T, et al. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer [ J ]. Ann Thorac Surg, 2008,85 (4) : 1430 - 1432.
  • 5Eren B, Sar M, Oz B, et al. MMP-2, TIMP-2 and CD44v6 expression in non-small-cell lung carcinomas [ J ]. Ann Acad Med Singapore, 2008, 37(1) :32 -39.
  • 6Cichy J, Kulig P, Pure E. Regulation of the release and function of tumor cell-derived soluble CD44 [ J ]. Biochim Biophys Acta, 2005, 1745( 1 ) :59 - 64.
  • 7闻世凤.放射免疫显像[M]//李林法.肿瘤靶向分子影像.北京:科学出版社,2006:98-125.
  • 8Goldenberg D M, Chatal J F, Barbet J, et al. Cancer imaging and therapy with bispecific antibody pretargeting[ J]. Update Cancer Ther, 2007, 2(1) : 19 -31.
  • 9Egri G, Takats A. The immunodiagnosis of lung cancer with monoclonal antibodies [ J]. Med Sci Monit, 2005, 11 (9) : RA296 - RA300.
  • 10Hage R, de-la-Riviere A B, Seldenrijk C A, et al. Update in pulmonary carcinoid tumors : a review article [ J]. Ann Surg Oncol, 2003, 10 ( 6 ) : 697 - 704.

共引文献9

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部